title: Risk factors for tumor lysis syndrome in childhood acute myeloid leukemia treated with a uniform protocol without rasburicase prophylaxis.
authors.affiliation: Department of Pediatrics, Sapporo Hokuyu Hospital , Sapporo , Japan.
authors.forename: Kenji
authors.initials: K
authors.lastname: Kishimoto
authors.forename: Ryoji
authors.initials: R
authors.lastname: Kobayashi
authors.forename: Mizuho
authors.initials: M
authors.lastname: Ichikawa
authors.forename: Hirozumi
authors.initials: H
authors.lastname: Sano
authors.forename: Daisuke
authors.initials: D
authors.lastname: Suzuki
authors.forename: Kazue
authors.initials: K
authors.lastname: Yasuda
authors.forename: Akihiro
authors.initials: A
authors.lastname: Iguchi
authors.forename: Kunihiko
authors.initials: K
authors.lastname: Kobayashi
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002454:Cell Differentiation; D002648:Child; D002675:Child, Preschool; D002880:Chromosomes, Human, Pair 11 / Q000235:genetics; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D005260:Female; D005500:Follow-Up Studies; D006074:Gout Suppressants / Q000009:adverse effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D009000:Monocytes / Q000473:pathology*; D011379:Prognosis; D012307:Risk Factors; D014178:Translocation, Genetic / Q000235:genetics*; D015275:Tumor Lysis Syndrome / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D014503:Urate Oxidase / Q000009:adverse effects*; D014527:Uric Acid / Q000378:metabolism
chemical_list: D006074:Gout Suppressants; C469709:rasburicase; D014527:Uric Acid; D014503:Urate Oxidase